Stocks and Investing Stocks and Investing
Wed, March 11, 2020
[ 12:00 AM ] - WOPRAI
Ashish Sabadra Maintained (TRU) at Strong Buy with Decreased Target to $93 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Lloyd Walmsley Maintained (BKNG) at Strong Buy on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Anthony Pettinari Maintained (AVY) at Hold with Decreased Target to $124 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Jonathan Reeder Upgraded (AWR) to Hold and Held Target at $84 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Christopher Glynn Maintained (WCC) at Buy with Decreased Target to $64 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Justin Long Maintained (WAB) at Buy with Decreased Target to $80 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Keyur Parekh Upgraded (SNY) to Strong Buy on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Richard Hill Maintained (SPG) at Hold with Decreased Target to $120 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
David Lebowitz Maintained (SNDX) at Hold with Increased Target to $10 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Alethia Young Reiterated (VRTX) at Buy with Increased Target to $275 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Luis Amadeo Initiated (SPXC) at Buy on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Ken Goldman Upgraded (THS) to Buy and Held Target at $45 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Nicole Miller Regan Maintained (THG) at Buy with Decreased Target to $130 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
John Baugh Initiated (UFPI) at Strong Buy and Held Target at $55 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Andrew Kligerman Upgraded (UNM) to Hold and Held Target at $18 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Jon Windham Maintained (WM) at Strong Buy with Decreased Target to $131 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
PJ Juvekar Maintained (WLK) at Hold with Decreased Target to $40 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Neel Kumar Maintained (WLK) at Hold with Decreased Target to $46 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Frank Louthan Downgraded (WOW) to Hold on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Zack Silver Downgraded (WOW) to Hold and Decreased Target to $6 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
James Lee Maintained (TCOM) at Strong Buy with Decreased Target to $35 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Frank Morgan Upgraded (CHE) to Buy and Increased Target to $535 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Reiterated (CDMO) at Strong Buy with Decreased Target to $9 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
PJ Juvekar Maintained (CE) at Hold with Decreased Target to $88 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Anthony Pettinari Maintained (CCK) at Strong Buy with Decreased Target to $83 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Michael Ciarmoli Upgraded (BWXT) to Strong Buy and Held Target at $60 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Jen Redding Upgraded (BURL) to Buy and Increased Target to $246 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Jonathan Reeder Maintained (WTRG) at Hold with Increased Target to $48 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Phil Gresh Maintained (XOM) at Hold with Decreased Target to $50 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Difei Yang Reiterated (AKBA) at Strong Buy with Decreased Target to $15 on, Mar 11th, 2020

Difei Yang Reiterated (AKBA) at Strong Buy with Decreased Target to $15 on, Mar 11th, 2020


Published on 2024-10-26 23:35:16 - WOPRAI, Difei Yang
  Print publication without navigation


Difei Yang of Mizuho, Reiterated "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Decreased Target from $16 to $15 on, Mar 11th, 2020.

Difei has made no other calls on AKBA in the last 4 months.



There are 2 other peers that have a rating on AKBA. Out of the 2 peers that are also analyzing AKBA, 0 agree with Difei's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Difei

  • Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $13 on, Thursday, February 20th, 2020
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $16 on, Monday, November 18th, 2019
Contributing Sources